Q, [DS] & Corruption

COVID-19: AstraZeneca likely provided an “incomplete view of efficacy data”


NIAID Statement on AstraZeneca Vaccine. National Institute of Allergy and Infectious Diseases (NIAID) – AstraZeneca likely provided an “incomplete view of efficacy data” on COVID-19 vaccine from a large scale U.S. trial  “Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data. We urge the company to work with the DSMB to review…

This content is for Q17c Membership, Classified Membership, and LifeTime Patriot Membership members only.
Login Join Now
QNavy is a pool of 3 former Navy Officers, U.S. Navy & French Navy, who served proudly their countries, specialized in conflict analysis as per their respective skills & experience on Special Ops. #NavyVetUnited

Israel Defense Forces pounds targets in Gaza Strip

Previous article

Yemen: Iran-backed Ansar Allah spreads a video affirming downing an U.S. MQ-9 UAV

Next article

You may also like


Comments are closed.